Replies to post #394883 on Amarin Corp Plc (AMRN)

[rosemountbomber]

If AMRN partnered with TEVA for an AG, TEVA would have the largest available supply and payer/pharmacy contacts and contracts to successfully compete with and possibly dominate other generics.

Duke, I think you make a very salient point. I have always been concerned about how an AG from AMRN could possibly bully its way into pharmacies when those Generic cos have so many products in their relationship with the pharmacies. Running it through Teva would definitely level the playing field.

On another note I use to buy the argument that Amarin could not bring out an AG too soon because it would affect EU reimbursement discussions. I am sort of moving away from that idea as I doubt anything could make those reimbursement decisions any more difficult.